Dodecafluoropentane emulsion (DDFPe), an advanced oxygen transport drug, given IV at 90-min intervals maintains viability in the penumbra during cerebral ischemia in the standard rabbit anterior stroke model (STND). This study investigated shortened dosage schedules of DDFPe in nonstandard posterior (NSTND) strokes following occlusions of the posterior cerebral arteries. DDFPe given at shortened schedules of 30 or 60-min injection intervals will reduce neurological deficits, percent stroke volume (%SV), and serum glutamate levels in NSTND ischemic strokes. New Zealand White rabbits (N = 26) were randomly placed into three groups: A (n = 9) controls given saline injections every 60 min, B (n = 9) 2 % DDFPe given IV every 30 min, and C (n = 8) DDFPe every 60 min. Injections began 1 h after embolization. Groups were subdivided into STND and NSTND based on angiographically verified embolization of the cerebral arteries. Neurological assessments and blood samples were done at 0.5–1-h intervals. Rabbits were euthanized at 7 h following embolization. Stained brain slices were measured for %SV. The 30 and 60-min subgroups did not differ and were combined as DDFPe-STND or DDFPe-NSTND groups. In the DDFPe-STND stroke group, the %SV, neurological assessment scores (NAS), and serum glutamate were decreased vs. STND controls (p = 0.0016, 0.008, and 0.016, respectively). In the DDFPe-NSTND stroke group, %SV, NAS, and serum glutamate did not differ statistically compared to NSTND controls (p = 0.82, 0.097, and 0.06, respectively). More frequent dosage schedules provided no additional improvement. In anterior strokes, DDFPe improves recovery but not in the more severe NSTND strokes.
This is a preview of subscription content, log in to check access.
Author Contributions Statement
AB conceived the study and designed the data collection. AB obtained research funding. MCA, JL, KC, and AB collected the data. MCA, RDS, WCC, and AB provided statistical advice on study design and analyzed the data. MCA, KC, WCC, and AB drafted the manuscript, and all authors contributed to its revision.
Compliance with Ethical Standards
All animal procedures were approved by the Institutional Care and Use Committee.
Sources of Funding
This project was supported by the Fund to Cure Stroke, a grant fund of the University of Arkansas for Medical Sciences Foundation (to author AB) and by the NIGMS IDeA Award P30 GM110702 (sponsoring author AB).
Conflict of Interest
A patent has been applied for the use of dodecafluoropentane for stroke therapy by authors WCC and RDS.
Johnson JL, Dolezal MC, Kerschen A, Matsunaga TO, et al. (2009) In vitro comparison of dodecafluoropentane (DDFP) perfluorodecalin (PFD), and perfluoroctylbromide (PFOB) in the facilitation of oxygen exchange. Artif Cell Blood 37:156–162. doi:10.1080/10731190903043192CrossRefGoogle Scholar
Flores R, Hennings LJ, Lowery JD, Brown AT, et al. (2011) Microbubble-augmented ultrasound sonothrombolysis decreases intracranial hemorrhage in a rabbit model of acute ischemic stroke. Investig Radiol 46:419–424. doi:10.1097/RLI.0b013e31820e143aCrossRefGoogle Scholar
Zhao BQ, Suzuki Y, Kondo K, Kawano K, et al. (2001) Cerebral hemorrhage due to heparin limits its neuroprotective effects: studies in a rabbit model of photothrombotic middle cerebral artery occlusion. Brain Res 902:30–39CrossRefPubMedGoogle Scholar
Zhao BQ, Suzuki Y, Kondo K, Kawano K, et al. (2002) A novel MCA occlusion model of photothrombotic ischemia with cyclic flow reductions: development of cerebral hemorrhage induced by heparin. Brain Res Protocol 9:85–92CrossRefGoogle Scholar
Zhao BQ, Suzuki Y, Kondo K, Ikeda Y, et al. (2001) Combination of a free radical scavenger and heparin reduces cerebral hemorrhage after heparin treatment in a rabbit middle cerebral artery occlusion model. Stroke 32:2157–2163CrossRefPubMedGoogle Scholar
Chen ZZ, Jiang XD, Zhang LL, Shang JH, et al. (2008) Beneficial effect of autologous transplantation of bone marrow stromal cells and endothelial progenitor cells on cerebral ischemia in rabbits. Neurosci Lett 445:36–41CrossRefPubMedGoogle Scholar
Dorňák T, Kral M, Hazlinger M, Herzog R, et al. (2015) Posterior vs. anterior circulation infarction: demography, outcomes, and frequency of hemorrhage after thrombolysis. Int J of Stroke 10:1224–1228. doi:10.1111/ijs.12626Google Scholar
Ohishi H, Nishijima M, Ogawa A, Yoshimoto T, et al. (1984) Protective effect of mannitol in cerebral infarction—CT findings and physiological observation in experimental cerebral infarction in dogs. No Shinkei Geka 12:153–158PubMedGoogle Scholar
Aliprandi A, Longoni M, Stanzani L, Tremolizzo L, et al. (2005) Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake. J Cereb Blood Flow Metab 25:513–519CrossRefPubMedGoogle Scholar